Crohns Disease Clinical Trials in San Francisco, California
2 recruitingSan Francisco, California
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche600 enrolled355 locationsNCT06819878
Recruiting
Phase 1Phase 2
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Tr1X, Inc.39 enrolled13 locationsNCT06721962